Cytoskeletal agents inhibit motility and adherence of human tumor cells. Cytoskeletal agents have been demonstrated to inhibit stimulated motility and substrate adherence by the human tumor cell line, A2058. cis-tubulozole, taxol, and cytochalasin D were tested for their effects on chemotaxis in response to a tumor cytokine, autocrine motility factor, and on adherence to several substrata: laminin-and gelatin-coated dishes as well as tissue culture plastic. Cytochalasin D, which inhibits microfilament polymerization, abolished stimulated motility. Taxol, which stabilizes microtubules, decreased stimulated motility to a greater degree than cis-tubulozole, which inhibits microtubular polymerization. In contrast, cis-tubulozole had the greatest inhibitory effect on adherence with a gelatin substratum more affected (100% inhibition) than tissue culture plastic (90%) or laminin substratum (52%). Taxol affected adherence in the same order but less than cis-tubulozole.
which stabilizes microtubules, decreased stimulated motility to a greater degree than cis-tubulozole, which inhibits microtubular polymerization. In contrast, cis-tubulozole had the greatest inhibitory effect on adherence with a gelatin substratum more affected (100% inhibition) than tissue culture plastic (90%) or laminin substratum (52%). Taxol affected adherence in the same order but less than cis-tubulozole.
Cytochalasin D had no significant effect on adherence to laminin with moderate inhibition of adherence to tissue culture plastic or gelatin. These data suggest that, in these tumor cells, microfilaments are more crucial for motility than adherence, but the dynamic polymerization and depolymerization of microtubules are required for both types of cellular activities.
Migration is an essential feature in the dissemination of metastatic tumor cells throughout the host. Each time a metastasizing tumor cell traverses a biological barrier such as a basement membrane, there appear to be at least three necessary stages of cellular function [1] : adherence to an extracellular matrix, release of proteolytic enzymes, and the motile response itself. It is probable that these stages occur concertedly as the cell progresses.
Neutrophils [2] and fibroblasts [3] have been shown to require activation of the cytoskeleton for locomotion. Pharmacologic agents that act on cytoskeletal components have been tested extensively for their effect on neutrophil and fibroblast locomotion. Agents such as coichicine, which inhibits microtubular polymerization, have been shown to inhibit motility in fibroblasts [4] and directional motility in polymorphonuclear leukocytes [5] . Coichicine has also been shown to inhibit leading edge migration and adherence to an endothelial monolayer by B16-FlO murine melanoma cells [6] . Taxol, which stabilizes microtubules, has been demonstrated to affect motility in a variety of cells [7, 8] . The cytochalasins B and D, which inhibit actin polymerization [9, 10] , also abolish motility [11] [12] [13] in fibroblasts, neutrophils, and glioma cells, respectively.
In this report, we have employed the cis isomer of tubulozole © 1993 by the International Society of Nephrology which, like colchicine, inhibits microtubular polymerization [14] , taxol, and the cytochalasins B and D. Using the A2058
human melanoma cell line, we have studied the effects of these agents upon motility stimulated by autotocrine motility factor (AMF), a cytokine which these same cells synthesize [15, 16] . We have also measured their effect on adherence to lamininand gelatin-coated dishes as well as tissue culture plastic. We wish to compare the effect of these pharmacologic agents in tumor cells to the well-documented observations made in neutrophils and fibroblasts. We also have attempted to utilize these agents as tools in order to assess the relative contribution of microtubules and microfilaments to components of the motile process.
Methods

Materials
The polycarbonate nucleopore membranes (8 sm pore size, polyvinylpyrrolidone-free), the 48-well micro-chemotaxis chambers, the 12-well manifold chamber, and the modified 
Cell culture
The human melanoma cell line A2058, originally isolated by Todaro, Fryling and DeLarco [17] , was maintained as previously described [15] .
Production of autocrine motility factor (AMF)
This was accomplished as before [18] , except that Phenol Red-free Dulbecco's Modified Eagle's medium (DMEM) was used for production of the factor. The AMF preparation was concentrated 25-fold at neutral pH using an Amicon ultrafiltration assembly that retained species of Mr> 30,000. AMF served as a positive control for stimulated motility.
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Cell motility assay
The assay used to determine cell motility was described previously in detail [19] . Each pharmacologic agent was prepared at 20 x the final concentration and then added at a 1:20 dilution to cell suspensions. The cells were incubated in the presence of the drug for one hour at room temperature then added to the upper wells of the micro-chemotaxis chamber (100,000 cells/well). Cells were maintained in appropriate concentrations of the agents throughout the assay. All experiments were performed in triplicate with both AMF (chemotactic positive control) and 0.1% BSA-DMEM (unstimulated random motility) added separately to the bottom wells for each concentration of every agent. At the end of a four hour incubation at 37°C, filters were removed, fixed and stained with Diff-Quik (Baxter Scientific, McGaw Park, Illinois, USA), then mounted on glass slides. Cells that had migrated were quantitated by light microscopy under high power field (HPF) at a magnification of 400x. Five randomly chosen HPF's were counted for each replicate.
Reversibility of cytoskeletal agents Cells were incubated at room temperature in the presence of the cytoskeletal agents diluted in 0.1% BSA-DMEM for one hour, centrifuged, and either washed twice with the same dilution of drug or in 0,1% BSA-DMEM. The cells were then allowed a 30-minute recovery period at room temperature prior to the start of the chemotaxis assay. Untreated cells, which had undergone similar incubations and centrifugations, were tested concomitantly as controls.
Adherence to tissue culture plastic Cells were treated with the cytoskeletal agents at appropriate concentrations for one hour prior to the start of the assay as well as throughout the assay. After the preincubation, 1 x 106 cells were added in triplicate to 12-well tissue culture plates. After a 90 minute incubation at 37°C, the cells were washed twice with Dulbecco's Phosphate Buffered Saline (DPBS) without Ca or Mg + to remove non-adherent cells, and then detached using 100 /l of trypsin-EDTA. The adherent cells were quantitated in the presence of Trypan blue stain using a hemocytometer.
Production of laminin Laminin was purified from the Engelbreth-Holm-Swarm tumor as described [20, 21] , and its homogeneity was verified by electrophoretic analysis.
Adherence to laminin or gelatin Using a 96-well Immulon 1 Dynated Microfitter System, 3 sg/well of laminin or gelatin in a 0.05 ml volume of DPBS with Ca and Mg was allowed to coat the wells overnight. The wells were then washed three times with DPBS with Ca + and Non-specific binding of cells to the plastic was blocked by incubating the coated wells in 0.1% BSA in DMEM for 45 minutes. Cells which had been pretreated with cytoskeletal agents for one hour were then added to the wells at 50,000 to 75,000 cells/well. Cells were maintained in appropriate concentrations of the agents throughout the assay. After a two hour incubation at 37°C, the wells were washed twice with DPBS without Ca + orMg and the cells were detached using 50 tl trypsin-ethylenediaminetetraacetic acid. The cells were then counted with a hemocytometer as described above.
Chemotaxis of pre-adherent cells
For the pre-adherence assays, we used a 12-well manifold chamber which allows addition to and removal of material from the bottom well during the course of an assay. We added 150,000 untreated cells to the top wells of the chamber and allowed them to attach for one hour at 37°C with only 0.1% BSA-DMEM present in the bottom wells. After attachment, either AMF (chemotactic positive control) or 0.1% BSA-DMEM (unstimulated random motility) was carefully added to the lower wells so that the attached cells remained undisturbed in the upper well. Cytoskeletal agents (10 M) were then added to the cells in the upper wells. After a four hour incubation at 37°C the filters were removed, stained with Diff-Quik, and mounted on glass slides. The migrated cells, in triplicate wells, were counted by light microscopy as described above.
A regular chemotaxis assay was run concurrently in which the cytoskeletal agent was added to the cells immediately prior to placing them in the chamber. For this assay there was no period of pre-attachment so that either AMF or 0.1% BSA-DMEM was in the lower wells from the start of the assay. This also was run for four hours, then was fixed, stained and counted as described.
Results
Effect of cytoskeletal agents on motility We employed the human melanoma cell line, A2058, as a model for tumor cell motility and used its own autoctrine motility factor (AMF) to induce the motile response [15, 16] . In employing this model, cells were pretreated for one hour with cytoskeletal agents at different concentrations and then their motility was compared to that of untreated control cells.
We first wanted to assess the role of microtubular aggregation and disaggregation in tumor cell locomotion. We employed the drug tubulozole, which has two stereoisomeric forms: the cis isomer which has been shown to inhibit microtubular polymerization, and the trans isomer which has little effect on polymerization even at 100-fold higher concentrations [14] . In A2058 cells cis-tubulozole, but not the trans stereoisomer, inhibited AMF-stimulated motility in a concentration-dependent manner (Fig. 1A) . Treatment of the cells with 10 M cis-tubulozole reduced the stimulated motility by at least 60%. This inhibitory effect was partially reversible during a one hour washout experiment ( Table 1) .
The pharmacologic agent, taxol, which acts by stabilizing microtubules and promoting their polymerization, also inhibited motility in a concentration-dependent manner (Fig. 1B) . Treatment of A2058 cells with 1 to 10 M taxol reduced the stimulated motility response by at least 90%. Taxol also had a very broad range of activity with some inhibition seen even at concentrations as low as 0.01 sM. Unlike the other agents tested, the taxol effect was not readily reversible (Table 1) .
Both cytochalasin B and D effectively inhibited the locomotive response in a concentration-dependent manner (Fig. 1C) . Cytochalasin D, which is more specific for microfilaments, was inhibitory at lower concentrations than cytochalasin B, with essentially complete inhibition at 1.0 sM and 10 jsM for each a Cells were incubated at room temperature with the cytoskeletal agents diluted in 0.1% BSA-DMEM for one hour, then centrifuged and washed twice with the same agents. They were allowed an additional 30-minute incubation period prior to the start of the chemotaxis assay.
b Cells were incubated at room temperature with the cytoskeletal agents diluted in 0.1% BSA-DMEM for one hour, then centrifuged and washed in 0.1% BSA-DMEM. They were allowed a 30-minute recovery period prior to the chemotaxis assay. C Motility is expressed as a % of control which is the total motility minus unstimulated random motility for cells treated identically but without the addition of cytoskeletal agents. For cis-tubulozole, taxol, and cytochalasin D, total motility was 72.3 cells/HPF and random motility was 3.9 cells/HPF. For cytochalasin D, total motility was 64.7 cells/HPF and random motility was 3.7 cellslHPF. Stimulated motility was measured in triplicate using AMF as chemoattractant. Random motility was measured with 0.1% BSA-DMEM in the bottom wells. agent, respectively. This inhibition was fully reversible ( Table   1) .
Effect of cytoskeletal agents on adherence When non-ciliated cells move, they must be able to contact and transiently adhere to the substratum. During fibroblast locomotion, both microfilaments and microtubules have been shown to play a role in this contact formation [3] . We wished to determine whether the effect of the cytoskeletal agents on A2058 motility represented primarily an inhibition of their ability to adhere. To accomplish this, we examined the effect of each agent on adherence to several different substrata: tissue culture plastic to which the cells are presumed to bind in a non-specific fashion; gelatin which is used to coat the membranes in the chemotaxis assays; and laminin which is known to bind to a high affinity receptor on the surface of these cells [22] .
The adherence properties of A2058 cells which had been preincubated for one hour with each pharmacologic agent, were compared to those of untreated cells.
Cis-tubulozole had a profoundly inhibitory effect on adher-
ence to all of the tested substrata ( Fig. 2A) . Adherence to gelatin and tissue culture plastic were most profoundly affected, with > 90% inhibition at concentrations of 3 to 10 sM cistubulozole and > 80% at 1 sM. Even at concentrations of cis-tubulozole as low as 0.1 jzM, which has little effect on AMF-stimulated motility, adherence was significantly affected (26.5 4.5% inhibition on gelatin dishes and 15.4 7.0% on tissue culture plastic). Cell attachment to laminin was also inhibited, but not as profoundly: at 10 sM cis-tubulozole, the inhibition of adherence was only 52.0 4.6%. This effect decreased at lower concentrations. Taxol also affected adherence to each of the tested substrata (Fig. 2B) . As was found with cis-tubulozole, taxol had a greater effect on cellular attachment to gelatin and tissue culture 1 o5 plastic. However, taxol generally did not completely abolish adherence to either: at a concentration of 10 sM, adherence to gelatin was reduced by 77.8 7.4% and adherence to tissue culture plastic was reduced by 56.6 8.5%. As the concentration of taxol decreased, this inhibitory effect also decreased in a linear fashion. However, taxol had only a minimal effect on cellular attachment to laminin. Only the highest tested concen---i trations (1 to 10 .LM) of taxol lowered laminin adherence to levels significantly less than those of untreated cells. These results, together with those from the experiments with cismay be more important in the non-specific adherence of melanoma cells than in the receptor-mediated adherence. Cytochalasin D concentration, M 2C), there was no significant effect on adherence to laminin. Adherence to tissue culture plastic and gelatin-coated plates was moderately inhibited (34.7 8.3% for tissue culture and 59.2 9.4% for gelatin). This inhibitory effect occurred primarily at the highest tested concentration (10 tIM) of cytochalasin D and fell rapidly as the concentration decreased.
Because the cytoskeletal agents all inhibited adherence to varying degrees depending on the substratum of attachment, it remained unclear whether their effect on motility was secondary to their effect on adherence. Therefore, we allowed A2058 cells to pre-adhere to the gelatin-coated polycarbonate membrane used in the motility assays for one hour prior to adding an appropriate agent to the cells in the upper chamber or adding AMF to the lower chamber (Fig. 3) . Treating pre-adherent cells with taxol resulted in less than or equal motility compared to non-preadhered cells (90 vs. 71% inhibition, respectively). Treating pre-adherent cells with cis-tubulozole resulted in slightly increased motility compared to non-preadhered cells (69 vs. 81% inhibition, respectively). Treating pre-adherent cells with cytochalasin D resulted in measurable but very low motility (94% inhibition). Cytochalasin-treated cells that were not allowed to preadhere did not move at all.
To compare the effects of the cytoskeletal agents on adherence to gelatin versus motility through a gelatin-coated filter, we ran the motility and adherence assays concurrently, using the same cells and the same concentrations of the two agents. Cis-tubulozole inhibited adherence more profoundly than motility at each concentration tested (Fig. 4A) . In fact, it was reproducibly found that at an intermediate concentration such as 1 jIM, cis-tubulozole essentially abolished adherence while the motility was only partially inhibited. In contrast, taxol (Fig.   4B ) and cytochalasin D (Fig. 4C ) appeared to have greater effects on motility than on adherence. For cytochalasin D, the two effects parallel each other with motility more profoundly inhibited at each concentration than adherence. For taxol, the inhibitory effect on adherence has a more shallow slope so that adherence is affected over a broader range of concentrations, but motility is more profoundly reduced at the highest concentrations.
Effect of each agent on random versus directed motility Previous reports have indicated that microtubules are necessary for cell polarization and directionality. In fact, colchicine has been reported to inhibit primarily directional motility rather than random motility [5] . Because AMF has both chemotactic and chemokinetic properties [15, 161, we utilized this cytokine to perform an abbreviated checkerboard analyses for each of the three cytoskeletal agents. In each checkerboard (Fig. 5) , the left upper square shows background or unstimulated random motility. The left lower square measures chemotaxis or directed motility in a positive gradient. The right upper square shows how the cells respond to a negative gradient. The right lower . These data indicate that there is no preferential effect on directed or stimulated random motility by any of the tested agents.
Discussion
We have studied how agents that act upon the cytoskeleton affect two properties of a metastatic cell line: stimulated migration to the tumor cytokine, autocrine motility factor (AMF), and adherence to a variety of substrata. Cis-tubulozole, taxol, and the cytochalasins B and D all inhibited stimulated motility in A2058 cells. The cytochalasins essentially abolished all motility, taxol inhibited it profoundly, but cis-tubulozole had a less uniform effect with a range of 60 to 100% inhibition. The effect of these agents on adherence was essentially in the opposite order of potency. Cis-tubulozole profoundly inhibited adherence of cells to both tissue culture plastic and gelatincoated dishes. This effect was significant but of less magnitude on laminin-coated dishes. Taxol similarly inhibited adherence in the order: gelatin-coated dishes > tissue culture plastic > laminin-coated dishes. However, in each case, the inhibition of adherence caused by taxol was less than that caused by cis-tubulozole. Cytochalasin D, in contrast, had no significant effect on adherence to laminin-coated dishes and little effect on adherence to tissue culture plastic but moderately inhibited adherence to gelatin-coated dishes.
In neutrophils and fibroblasts, microtubules appear to be necessary for the development of cell polarity [4, 5] and for the formation of the focal contacts that provide traction and stability [3] . In A2058 cells, the microtubule-specific agent cistubulozole affected adherence of cells to gelatin-coated plates more than it affected motility on gelatin-coated filters. However, the motility assays performed with pre-attached cells indicated that cis-tubulozole significantly affected the locomotive capacity of these tumor cells. Furthermore, this inhibition was of similar magnitude for both directed and random stimulation. The fact that the cells continued to locomote even when their capacity to adhere was severely inhibited could reflect an ability of these cells to synthesize substrate during the course of a four hour assay or could reflect the fact that locomotion only requires transient focal contacts with the substratum. In comparison, the pattern of inhibition with taxol appeared to be Fig. 5 . Effect of the cytoskeletal agents on motility in abbreviated checkerboard assays. Cells were preincubated for one hour in 0.1% BSA-DMEM (A), 10 jsM cis-tubulozole (B), or 10 LM taxol (C). Half of the cells were then tested in a routine motility assay in which total directional motility (with AMF in the bottom chamber) was compared to random motility (with 0.1% BSA-DMEM in the bottom). The second half of the cells had AMF added directly to them. These cells were also tested for motility when AMF (stimulated random motility) vs. 0.1% BSA-DMEM (negative gradient) was in the lower chamber.
reversed: motility on gelatin substrata was affected more than adherence. When taxol was added to pre-attached cells, motility was even more profoundly inhibited-as though the cells were frozen in the spread out configuration and could not squeeze through the 8 sm pores. As with cis-tubulozole, taxol had similar inhibitory effects on both chemotaxis and chemokinesis. Our data thus indicate that, like leukocytes, these tumor cells require the dynamic association and dissociation of microtubules both for stimulated motility and for attachment to certain substrata. Unlike its effect on neutrophils, the antimicrotubular polymerizing agent has similar effects on both chemotaxis and chemokinesis.
Previous work with neutrophils and fibroblasts has indicated that microfilaments are necessary to stabilize focal contacts [3, 23] and to act as a driving force in pseudopod extension and subsequent locomotion [24] [25] [26] . In A2058 cells, the cytochalasins had a profound effect on stimulated motility, This occurred even when the cells were pre-attached, although there was a slight lessening of the otherwise total inhibition, However, cytochalasin D had far less effect on adherence: only adherence to gelatin was significantly inhibited. Thus, our data indicate that microfilaments are essential for motility but less so for adherence in these human tumor cells.
Our findings have implications for cancer therapeutic regimens which include cytoskeletal agents. Colchicine, vinbiastine, cis-tubulozole, and taxol, all of which affect microtubules, appear to have widespread effects on several components of the metastatic process, including the capacity of the cells to locomote and to adhere to a variety of substrata. In vivo it is probable that adherence to basement membranes is mediated through relatively high-affinity cell surface receptors. Our data with laminin as substrate suggest that such adherence may be somewhat less susceptible to these agents, but are not unaffected by them. Taxol, as distinct from the other agents, was found to be difficult to remove from these tumor cells. This could have advantages in antineoplastic regimens; however, because the drug also affects neutrophils [8] , taxol may significantly compromise a patient's immune defenses. The reversibility of taxol's effect on microtubules may be function-related with changes in the cellular ultrastructure less readily reversible than changes in hormone synthesis (27] . It is interesting that agents such as the cytochalasins, which appear to affect motility far more than adherence, have had mixed results in tests as potential antineoplastic agents. This could be explained by the narrower spectrum of their effects as well as by their very rapid reversibility. Finally, it is noteworthy that these agents all 
